Literature DB >> 7722148

Intracoronary irradiation markedly reduces neointimal proliferation after balloon angioplasty in swine: persistent benefit at 6-month follow-up.

J G Wiedermann1, C Marboe, H Amols, A Schwartz, J Weinberger.   

Abstract

OBJECTIVES: This study examined the long-term efficacy of intracoronary irradiation for limiting neointimal proliferation after overstretch balloon angioplasty in a porcine model of restenosis. In addition, this study sought to identify any adverse late sequelae of this novel therapy for restenosis.
BACKGROUND: Restenosis after coronary angioplasty represents in part a proliferative response of vascular smooth muscle at the site of injury. We have shown previously that high dose intracoronary radiation induces focal medial fibrosis and markedly reduces neointimal proliferation early after balloon angioplasty in swine.
METHODS: Twenty-two juvenile swine underwent intervention at a target segment of the left coronary artery. In 11 swine, a 2-cm ribbon of iridium-192 was positioned at the target segment and 2,000 cGy was delivered to the vessel wall. Subsequently, overdilation balloon angioplasty was performed at the irradiated segment. In 11 control swine, overdilation balloon angioplasty was performed without previous irradiation. Twenty animals survived and underwent histopathologic analysis at 180 +/- 8 days.
RESULTS: Mean (+/- SD) neointimal area was 1.59 +/- 0.78 and 0.46 +/- 0.35 mm2 (p < 0.001) in control and irradiated animals, respectively. Mean percent area stenosis was 37.9 +/- 12.4% and 14.2 +/- 9.0% (p < 0.001) in the control and irradiated animals, respectively. Thus, by 6-month follow-up, intracoronary irradiation before balloon angioplasty had reduced the bulk of the neointimal lesion by 71.1% and reduced percent area stenosis by 62.5% compared with that in control animals. There was no evidence of radiation vasculopathy or myocardial damage at 6 months.
CONCLUSIONS: Intracoronary irradiation (2,000 cGy) produces persistent impairment of neointimal proliferation 6 months after balloon injury, with no evidence of late radiation sequelae.

Entities:  

Mesh:

Year:  1995        PMID: 7722148     DOI: 10.1016/0735-1097(95)00010-2

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  9 in total

Review 1.  Early and late effects of radiation treatment for prevention of coronary restenosis: a critical appraisal.

Authors:  O F Bertrand; S Lehnert; R Mongrain; M G Bourassa
Journal:  Heart       Date:  1999-12       Impact factor: 5.994

2.  Intracoronary radiation using radioisotope solution-filled balloons.

Authors:  J Weinberger
Journal:  Herz       Date:  1998-09       Impact factor: 1.443

Review 3.  Intracoronary brachytherapy in the Cath Lab. Physics dosimetry, technology and safety considerations.

Authors:  R Waksman
Journal:  Herz       Date:  1998-09       Impact factor: 1.443

4.  Intraarterial beta irradiation to reduce restenosis after PTCA. Experimental and clinical experience.

Authors:  V Verin; Y Popowski
Journal:  Herz       Date:  1998-09       Impact factor: 1.443

Review 5.  [Intravascular irradiation in the combined therapy and prevention of restenosis. Overview].

Authors:  D Baumgart; U Quast; R Erbel
Journal:  Herz       Date:  1997-12       Impact factor: 1.443

Review 6.  [Stent restenosis: therapy concepts and possibilities for prevention].

Authors:  P W Radke; J vom Dahl; H G Klues
Journal:  Med Klin (Munich)       Date:  1999-02-15

7.  Evaluation of three rhenium-188 candidates for intravascular radiation therapy with liquid-filled balloons to prevent restenosis.

Authors:  W Y Lin; S C Tsai; B T Hsieh; T W Lee; G Ting; S J Wang
Journal:  J Nucl Cardiol       Date:  2000 Jan-Feb       Impact factor: 5.952

8.  Endovascular irradiation prevents smooth muscle cell proliferation and neointimal hyperplasia in rabbits.

Authors:  L Xu; Y Wu; G Feng; M Oguchi; H Yokota; T Nakagawa; I Yamamoto
Journal:  J Tongji Med Univ       Date:  1999

Review 9.  [Intracoronary brachytherapy with strontium/yttrium-90. Initial experiences in Germany].

Authors:  S Silber; P von Rottkay; A Gielow; A Schneider; A Bauer; H Schöfer
Journal:  Herz       Date:  1998-09       Impact factor: 1.443

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.